opportunity analysis

Alexza Pharmaceuticals

Company Overview*

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) is a pharmaceutical development company focused on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system, or CNS, conditions. All of the Company's product candidates are based on its proprietary technology, the Staccato system. The Staccato system, vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. Because of the particle size of the aerosol, the drug is quickly absorbed through the deep lung into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous, or IV, administration but with greater ease, patient comfort and convenience. For more information please visit www.alexza.com.









*past representation


ALXA ImageALXA logo 2